Page 2480 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 151 Hematologic Changes in Pregnancy 2214.e3

107. Forster JG, Peltonen S, Kaaja R, et al: Plasma exchange in severe 132. Richey ME, Gilstrap LC, Ramin SM: Management of disseminated
postpartum HELLP syndrome. Acta Anaesthesiol Scand 46:955, 2002. intravascular coagulopathy. Clin Obstet Gynecol 38:514, 1995.
108. Pridjian G, Puschett JB: Preeclampsia. Part 1: clinical and pathophysi- 133. Kafrissen ME, Barke MW, Workman P, et al: Coagulopathy and
ologic considerations. Obstet Gynecol Surv 57:598, 2002. induced abortion methods: rates and relative risks. Am J Obstet Gynecol
109. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Col- 147:344, 1983.
laborative Group: CLASP: a randomised trial of low-dose aspirin for 134. Bacq Y: Acute fatty liver of pregnancy. Semin Perinatol 22:134, 1998.
the prevention and treatment of pre-eclampsia among 9364 pregnant 135. Mabie WC: Acute fatty liver of pregnancy. Gastroenterol Clin North Am
women. Lancet 343:619, 1994. 21:951, 1992.
110. Rotchell YE, Cruickshank JK, Gay MP, et al: Barbados Low Dose 136. Mabie WC, Dacus JV, Sibai BM, et al: Computed tomography in acute
Aspirin Study in Pregnancy (BLASP): a randomised trial for the pre- fatty liver of pregnancy. Am J Obstet Gynecol 159:142, 1988.
vention of pre-eclampsia and its complications. Br J Obstet Gynaecol 137. Vigil-De Gracia P: Acute fatty liver and HELLP syndrome: two distinct
105:286, 1998. pregnancy disorders. Int J Gynaecol Obstet 73:215, 2001.
111. Chappell LC, Seed PT, Briley AL, et al: Effect of antioxidants on the 138. Cardonick E, Iacobucci I: Use of chemotherapy during human preg-
occurrence of pre-eclampsia in women at increased risk: a randomized nancy. Lancet Oncol 5:283, 2004.
trial. Lancet 354:810, 1999. 139. Avilés A, Neri N: Hematological malignancies and pregnancy: a final
112. Lopez-Jaramillo P, Narvaez M, Weigel RM, et al: Calcium supplemen- report of 84 children who received chemotherapy in utero. Clin Lym-
tation reduces the risk of pregnancy-induced hypertension in an Andes phoma 2:173, 2001.
population. Br J Obstet Gynaecol 96:648, 1989. 140. Ward FT, Weiss RB: Lymphoma and pregnancy. Semin Oncol 16:397,
113. Morris CD, Jacobson SL, Anand R, et al: Nutrient intake and 1989.
hypertensive disorders of pregnancy: evidence from a large prospective 141. Sweet DL: Malignant lymphoma: implications during the reproductive
cohort. Am J Obstet Gynecol 184:643, 2001. years and pregnancy. J Reprod Med 17:198, 1976.
114. Atallah AN, Hofmeyr GJ, Duley L: Calcium supplementation during 142. Dilek I, Topcu N, Demir C, et al: Hematologic malignancy and preg-
pregnancy for preventing hypertensive disorders and related problems. nancy: a single-institution experience of 21 cases. Clin Lab Haematol
Cochrane Database Syst Rev (1):CD001059, 2002. 28:170, 2006.
115. Olsen S, Secher NJ, Tabor A, et al: Randomised clinical trials of fish 143. Anselmo AP, Cavalieri E, Enrici RM, et al: Hodgkin’s disease during
oil supplementation in high risk pregnancies. Br J Obstet Gynaecol pregnancy: diagnostic and therapeutic management. Fetal Diagn Ther
107:382, 2000. 14:102, 1999.
116. Proia A, Paesano R, Torcia F, et al: Thrombotic thrombocytopenic 144. Lishner M, Zemlickis D, Degendorger P, et al: Maternal and fetal
purpura and pregnancy: a case report and a review of the literature. outcome following Hodgkin’s disease in pregnancy. Br J Cancer 5:114,
Ann Hematol 81:210, 2002. 1992.
117. Elliott MA, Nichols WL: Thrombotic thrombocytopenic purpura and 145. Dildy GA, Moise KJ, Carpenter RJ, et al: Maternal malignancy
hemolytic uremic syndrome. Mayo Clin Proc 76:1154, 2001. metastatic to the products of conception: a review. Obstet Gynecol Surv
118. Tsai HM, Lian EC: Antibodies to von Willebrand factor-cleaving 44:535, 1989.
protease in acute thrombotic thrombocytopenic purpura. N Engl J 146. Horowitz NA, Benyamini N, Wohlfart K, et al: Reproductive organ
Med 339:1585, 1998. involvement in non-Hodgkin lymphoma during pregnancy: a system-
119. Furlan M, Robles R, Galbusera M, et al: von Willebrand factor-cleaving atic review. Lancet Oncol 14:e275, 2013.
protease in thrombotic thrombocytopenic purpura and the hemolytic- 147. Leslie KK: Chemotherapy and pregnancy. Clin Obstet Gynecol 45:153,
uremic syndrome. N Engl J Med 339:1578, 1998. 2002.
120. Weiner CP: Thrombotic microangiopathy in pregnancy and the post- 148. Schafer AI: Teratogenic effects of antileukemic chemotherapy. Arch
partum period. Semin Hematol 24:119, 1987. Intern Med 141:514, 1981.
121. McCrae KR, Cines DB: Thrombotic microangiopathy during preg- 149. Chelghoum Y, Vey N, Raffoux E, et al: Acute leukemia during preg-
nancy. Semin Hematol 34:148, 1997. nancy: a report on 37 patients and a review of the literature. Cancer
122. Esplin MS, Branch DW: Diagnosis and management of thrombotic 104:110, 2005.
thrombocytopenic microangiopathies during pregnancy. Clin Obstet 150. Reynosa E: Acute leukemia during pregnancy. J Clin Oncol 5:1098,
Gynecol 42:360, 1999. 1987.
123. Ezra Y, Rose M, Eldor A: Therapy and prevention of thrombotic 151. King CT: Antifungal therapy during pregnancy. Clin Infect Dis 27:1151,
thrombocytopenic purpura during pregnancy: a clinical study of 16 1998.
pregnancies. Am J Hematol 51:1, 1996. 152. Sobel J: Use of antifungal drugs in pregnancy: a focus on safety. Drug
124. Bell WR, Braine HG, Ness PM, et al: Improved survival in thrombotic Saf 23:77, 2000.
thrombocytopenic purpura-hemolytic uremic syndrome: clinical expe- 153. Lammer EJ, Chen DT, Hoar RM, et al: Retinoic acid embryopathy.
rience in 108 patients. N Engl J Med 325:398, 1991. N Engl J Med 313:837, 1985.
125. Rock GA, Shumak KH, Buskard NA, et al: Comparison of plasma 154. Carradice D, Austin N, Bayston K, et al: Successful treatment of acute
exchange with plasma infusion in the treatment of thrombotic throm- promyelocytic leukaemia during pregnancy. Clin Lab Haematol 24:307,
bocytopenia purpura. N Engl J Med 325:393, 1991. 2002.
126. Dashe JS, Ramin SM, Cunningham FG: The long-term consequences of 155. Giagounidis AA, Beckman MW, Giagounidis AS, et al: Acute promy-
thrombotic microangiopathy (thrombotic thrombocytopenic purpura elocytic anemia and pregnancy. Eur J Haematol 64:267, 2000.
and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 91:662, 156. Ali R, Ozkalemkas F, Ozcelik T, et al: Imatinib and pregnancy. J Clin
1998. Oncol 24:3812, 2006.
127. Davies GE: Thrombotic thrombocytopenic purpura in pregnancy with 157. Ault P, Kantarjian H, O’Brien S, et al: Pregnancy among patients with
maternal survival: case report. Br J Obstet Gynaecol 91:396, 1984. chronic myeloid leukemia treated with imatinib. J Clin Oncol 24:1204,
128. Rozdzinski E, Hertenstein B, Schmeiser T, et al: Thrombotic thrombo- 2006.
cytopenia purpura in early pregnancy with maternal and fetal survival: 158. Harrison C: Pregnancy and its management in the Philadelphia nega-
case report. Ann Hematol 64:245, 1992. tive myeloproliferative diseases. Br J Haematol 129:293, 2005.
129. Pritchard JA, Cunningham FG, Pritchard SA, et al: On reducing the 159. Passamonti M, Randi ML, Rumi E, et al: Increased risk of pregnancy
frequency of severe abruptio placentae. Am J Obstet Gynecol 165:1345, complications in patients with essential thrombocythemia carrying the
1991. JAK2 (617V>F) mutation. Blood 110:485, 2007.
130. Clark SL: New concepts of amniotic fluid embolism: a review. Obstet 160. Barbui T, Finazzi G: Myeloproliferative disease in pregnancy and other
Gynecol Surv 45:360, 1990. management issues. Hematology 1:146, 2006.
131. Bick RL: Disseminated intravascular coagulation and related syndromes: 161. Harrison CN, Robinson SE: Myeloproliferative disorders in pregnancy.
a clinical review. Obstet Gynecol Surv 40:462, 1985. Hematol Oncol Clin North Am 25:261, 2011.